API Unit Planned By Glenmark Life Sciences
The leading developer and manufacturer of select high-value, non-commoditized Active Pharmaceutical Ingredients (APIs), Glenmark Life Sciences has planned to set up an active pharmaceutical ingredient (API) manufacturing unit with a capacity of 999.70 million tpa. The new APU unit would be spread over 40 acres of land parcel and would be set up at Chincholi MIDC, in the Solapur district.
Firm has received the environmental clearance for the project and works on the project have commenced. It is expected to be completed by July 2025.
Also Read: API Bulk Drug Unit Planned By Vijayalakshmi Narasimhareddy Chemicals